Sawai Group Holdings Co., Ltd. (TYO:4887)

Japan flag Japan · Delayed Price · Currency is JPY
2,219.50
+6.00 (0.27%)
At close: Mar 6, 2026
5.49%
Market Cap 256.32B
Revenue (ttm) 200.68B
Net Income (ttm) 8.23B
Shares Out 115.49M
EPS (ttm) 70.88
PE Ratio 26.52
Forward PE 13.59
Dividend 56.00 (2.52%)
Ex-Dividend Date Mar 30, 2026
Volume 414,500
Average Volume 397,825
Open 2,185.00
Previous Close 2,213.50
Day's Range 2,163.50 - 2,219.50
52-Week Range 1,650.00 - 2,447.00
Beta 0.01
RSI 35.15
Earnings Date Feb 13, 2026

About Sawai Group Holdings

Sawai Group Holdings Co., Ltd., together with subsidiaries, engages in the research and development, manufacture, and marketing of generic pharmaceuticals. The company offers generic drugs in various dosage forms, including tablets, oral dispersing tablets, capsules, granules, injectables, tapes, ophthalmic or nasal solutions, syrups, and other forms for various therapeutic areas comprising cardiovascular, gastro-intestinal, blood/body fluid, other metabolic, antibiotics, central nervous system, antiallergics, anti-cancer, urogenital organs and... [Read more]

Sector Healthcare
Founded 1929
Employees 3,310
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 4887
Full Company Profile

Financial Performance

In fiscal year 2025, Sawai Group Holdings's revenue was 189.02 billion, an increase of 6.88% compared to the previous year's 176.86 billion. Earnings were 11.97 billion, a decrease of -12.60%.

Financial Statements

News

There is no news available yet.